Source study found
Story checked
A healthy Nordic diet may help you to live longer, but liver benefits remain unclear (opens in a new tab)
medicalxpress.com · 2026-10-10
Short answer
SupportedSupported.
The story matches what the study reports.
- 4 supported
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
A healthy Nordic diet may help you to live longer, but liver benefits remain unclear
medicalxpress.com · 2026-10-10
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Supported
Every claim holds up. All four claims match what the study reports.
- 4 supported
The source study
Estimating the effects of Nordic diets on the risk of major adverse liver outcomes: a target trial emulation across 2 cohorts in Sweden
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
4 claims in this storyShowing all 4 claimsChoose a verdict to focus the list.
Claim 1 of 4SupportedResearchers led by Michael Fridén at Aarhus University analyzed 24 years of dietary and health data from more than 64,000 Swedish adults in two population studies.View evidenceHide evidence
As statedmore than 64,000 Swedish adults; 24 years
Why this verdict
The abstract-level profile supports the core study description: two Swedish population-based cohorts, n=64,406, repeated measurements spanning about 24 years, used for dietary and health outcome analyses. The supplied scientific profile does not independently verify the named lead researcher or affiliation, but the substantive cohort/timeframe claim is supported.
Study evidence
Estimated 24-y risk of MALO under HND = 0.53% (95% CI: 0.38, 0.73).0.53% (95% CI: 0.38, 0.73)
“This study aimed to estimate the effects of adhering to an HND or the Nordic Nutrition Recommendations 2023 (NNR23) on the 24-y risk of MALO”
Study evidence
HND versus no intervention: estimated 24-year risk difference for all-cause mortality -2.67% (95% CI: -3.51, -1.85).-2.67% (95% CI: -3.51, -1.85)
“A similar analysis was performed for the secondary outcome, all-cause mortality.”
Claim 2 of 4SupportedThe team simulated what would have happened if everyone had followed modified versions of the Nordic diet or official regional dietary guidelines over the 24 years.View evidenceHide evidence
As stated24 years
Why this verdict
The paper profile describes target-trial emulation of hypothetical population-adapted adherence to a healthy Nordic diet and NNR23, compared with no intervention, using the parametric g-formula to estimate 24-year risks. Describing this as simulating what would have happened under modified diet interventions is consistent with the abstract-level evidence.
Study evidence
Estimated 24-y risk of MALO under HND = 0.53% (95% CI: 0.38, 0.73).0.53% (95% CI: 0.38, 0.73)
“This study aimed to estimate the effects of adhering to an HND or the Nordic Nutrition Recommendations 2023 (NNR23) on the 24-y risk of MALO”
Study evidence
HND versus no intervention: estimated 24-year risk difference for all-cause mortality -2.67% (95% CI: -3.51, -1.85).-2.67% (95% CI: -3.51, -1.85)
“A similar analysis was performed for the secondary outcome, all-cause mortality.”
Claim 3 of 4SupportedNeither diet showed a clear reduction in major adverse liver outcomes, and the article says the Nordic diet did not confer a statistically significant advantage in preventing these complications.View evidenceHide evidence
As stated0.53% vs 0.70% vs 0.64% modeled risk
Why this verdict
The MALO estimates show little to no clear reduction: HND 0.53%, NNR23 0.70%, and no intervention 0.64%, with risk-difference confidence intervals including zero for HND vs no intervention, NNR23 vs no intervention, and HND vs NNR23. The story’s hedged framing that neither diet showed a clear statistically significant reduction is supported.
Study evidence
Estimated 24-y risk of MALO under HND = 0.53% (95% CI: 0.38, 0.73).0.53% (95% CI: 0.38, 0.73)
“This study aimed to estimate the effects of adhering to an HND or the Nordic Nutrition Recommendations 2023 (NNR23) on the 24-y risk of MALO”
Claim 4 of 4SupportedFor all-cause mortality, the healthy Nordic diet was estimated to reduce the modeled 24-year risk of death by 2.67 percentage points compared with usual eating habits.View evidenceHide evidence
As stated2.67 percentage points
Why this verdict
The abstract profile reports all-cause mortality as a secondary outcome and gives HND versus no intervention risk difference of -2.67% with 95% CI -3.51 to -1.85. The story’s wording as an estimated modeled 24-year risk reduction matches the reported estimate, though interpretation remains conditional on the paper’s causal assumptions.
Study evidence
HND versus no intervention: estimated 24-year risk difference for all-cause mortality -2.67% (95% CI: -3.51, -1.85).-2.67% (95% CI: -3.51, -1.85)
“A similar analysis was performed for the secondary outcome, all-cause mortality.”
Context layer
What the story left out
Important study details the story did not include.
Causal interpretation depends on strong assumptions of no unmeasured confounding, no selection bias, and no measurement error.
The story mentions statistical modeling and uncertainty in the liver findings, but its listed caveats do not convey the paper’s explicit identifying assumptions, which are important for interpreting modeled causal effects from observational data.
From Target-trial emulation; parametric g-formula; Target-trial emulation using parametric g-formula
5 things the story did carry across
- The study used two Swedish population-based cohorts with n=64,406 and repeated measurements in 1997, 2008/2009, and 2019, spanning about 24 years.
- The analysis was a target-trial emulation using the parametric g-formula to estimate risks under hypothetical adherence to population-adapted HND, NNR23, or no intervention.
- The primary endpoint was major adverse liver outcomes, with no meaningful or statistically clear risk reduction for HND or NNR23 versus no intervention or each other.
- All-cause mortality was a secondary outcome; HND was associated with estimated reductions versus no intervention and versus NNR23.
- The diet interventions were hypothetical, population-adapted adherence scenarios derived from observational cohort data rather than randomized decades-long diet assignments.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
2
Evidence read
study summary
Lead result
secondary data
1Lead resultsecondary dataEstimate the 24-year causal effect of adhering to a healthy Nordic diet (HND) versus no intervention and versus NNR23 on risk of major adverse liver outcomes (MALO) by emulating a target trial across two Swedish population-based cohorts with repeated measurements (1997, 2008/2009, 2019).Target-trial emulation; parametric g-formulaExpandCollapse
In plain English
Target-trial emulation using two Swedish population-based cohorts (n = 64,406; repeated measurements in 1997, 2008/2009, 2019) estimated 24-year risks of major adverse liver outcomes (MALO) under hypothetical adherence to a population-adapted healthy Nordic diet (HND), the Nordic Nutrition Recommendations 2023 (NNR23), or no intervention using the parametric g-formula. Under the stated causal assumptions, little to no reduction in 24-y MALO risk was estimated for HND or NNR23 versus no intervention or versus each other; meaningful reductions were estimated for all-cause mortality with HND.
Key findings
- Estimated 24-y risk of MALO under HND = 0.53% (95% CI: 0.38, 0.73).0.53% (95% CI: 0.38, 0.73)
- Estimated 24-y risk of MALO under NNR23 = 0.70% (95% CI: 0.57, 0.90).0.70% (95% CI: 0.57, 0.90)
“This study aimed to estimate the effects of adhering to an HND or the Nordic Nutrition Recommendations 2023 (NNR23) on the 24-y risk of MALO”
What this piece can’t prove
- Interventions are population-adapted hypothetical adherence scenarios emulated from observational cohort data rather than randomized interventions.
1 further detail could not be confirmed from the summary.
2secondary dataEstimate the 24-year causal effect of adhering to HND versus no intervention and versus NNR23 on all-cause mortality using the same target trial emulation framework.Target-trial emulation using parametric g-formulaExpandCollapse
In plain English
Using a target-trial emulation with the parametric g-formula in two Swedish cohorts (n = 64,406 with repeated measures in 1997, 2008/2009, and 2019), the authors estimated 24-year effects of a population-adapted healthy Nordic diet (HND) versus no intervention and versus the Nordic Nutrition Recommendations 2023 (NNR23) on all-cause mortality. Under the study's identifying assumptions, they report risk differences favoring HND: -2.67% (95% CI: -3.51, -1.85) versus no intervention and -1.68% (95% CI: -2.75, -0.62) versus NNR23.
Key findings
- HND versus no intervention: estimated 24-year risk difference for all-cause mortality -2.67% (95% CI: -3.51, -1.85).-2.67% (95% CI: -3.51, -1.85)
- HND versus NNR23: estimated 24-year risk difference for all-cause mortality -1.68% (95% CI: -2.75, -0.62).-1.68% (95% CI: -2.75, -0.62)
“A similar analysis was performed for the secondary outcome, all-cause mortality.”
What this piece can’t prove
- Results rely on strong causal assumptions explicitly stated by the authors (no unmeasured confounding, no selection bias, no measurement error).
- Observational cohort data and parametric g-formula estimates are sensitive to model specification and potential residual confounding.
- All-cause mortality was a secondary outcome; the abstract does not provide detailed outcome ascertainment or covariate adjustment strategies.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Estimating the effects of Nordic diets on the risk of major adverse liver outcomes: a target trial emulation across 2 cohorts in Sweden
The American journal of clinical nutrition · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 27 candidate papers
Estimating the effects of Nordic diets on the risk of major adverse liver outcomes: a target trial emulation across 2 cohorts in Sweden
The American Journal of Clinical Nutrition · 2026 · PubMed, Europe PMC, Crossref
Best (but oft forgotten) practices: Applying the target trial framework in nutrition research
The American Journal of Clinical Nutrition · 2026 · PubMed, Europe PMC, Crossref
Food Substitution Modeling Approaches: A Methodological Study.
2026 · Europe PMC
Inconvenient for the investigator but convenient for science: trial registration in The American Journal of Clinical Nutrition
The American Journal of Clinical Nutrition · 2026 · Crossref
Ultra-processed Foods and Athletes: Current Insights on Classification, Use, Awareness, and Impact-A Narrative Review.
2026 · Europe PMC
Reply to M Takeuchi
The American Journal of Clinical Nutrition · 2026 · Crossref
And 21 more candidates considered.